Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

Similar articles for PubMed (Select 20354771)

1.

Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.

Creighton CJ, Chang JC, Rosen JM.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):253-60. doi: 10.1007/s10911-010-9173-1. Epub 2010 Mar 31. Review.

PMID:
20354771
2.

Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME, Thompson EW.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52. doi: 10.1007/s10911-010-9175-z. Epub 2010 Jun 4. Review.

PMID:
20521089
3.

microRNAs and EMT in mammary cells and breast cancer.

Wright JA, Richer JK, Goodall GJ.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):213-23. doi: 10.1007/s10911-010-9183-z. Epub 2010 May 25. Review.

PMID:
20499142
4.

Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Godde NJ, Galea RC, Elsum IA, Humbert PO.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):149-68. doi: 10.1007/s10911-010-9180-2. Epub 2010 May 12. Review.

PMID:
20461450
5.

The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.

Hollier BG, Evans K, Mani SA.

J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):29-43. doi: 10.1007/s10911-009-9110-3. Epub 2009 Feb 26. Review.

PMID:
19242781
6.

Epithelial-to-mesenchymal transitions and circulating tumor cells.

Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, Gilles C.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):261-73. doi: 10.1007/s10911-010-9174-0. Epub 2010 May 7. Review.

PMID:
20449641
7.

Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.

Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM.

Stem Cells. 2012 Feb;30(2):292-303. doi: 10.1002/stem.791.

8.

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JM, Chang JC.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5. doi: 10.1073/pnas.0905718106. Epub 2009 Aug 3.

9.

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.

Micalizzi DS, Farabaugh SM, Ford HL.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34. doi: 10.1007/s10911-010-9178-9. Epub 2010 May 19. Review.

10.

The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Taylor MA, Parvani JG, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Epub 2010 May 15. Review.

11.

Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Radisky ES, Radisky DC.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):201-12. doi: 10.1007/s10911-010-9177-x. Epub 2010 May 5. Review.

12.

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ.

Breast Cancer Res Treat. 2010 Nov;124(2):317-26. doi: 10.1007/s10549-010-0734-1. Epub 2010 Jan 20.

PMID:
20087650
13.

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C.

Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Review.

PMID:
18718806
14.

Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.

Foroni C, Broggini M, Generali D, Damia G.

Cancer Treat Rev. 2012 Oct;38(6):689-97. doi: 10.1016/j.ctrv.2011.11.001. Epub 2011 Nov 26. Review.

PMID:
22118888
15.

Mammary gland studies as important contributors to the cause of epithelial mesenchymal plasticity in malignancy.

Ford HL, Thompson EW.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):113-5. doi: 10.1007/s10911-010-9182-0. No abstract available.

PMID:
20544376
16.

Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.

Dunlap SM, Chiao LJ, Nogueira L, Usary J, Perou CM, Varticovski L, Hursting SD.

Cancer Prev Res (Phila). 2012 Jul;5(7):930-42. doi: 10.1158/1940-6207.CAPR-12-0034. Epub 2012 May 15.

17.

Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.

Vazquez-Martin A, Oliveras-Ferraros C, Cufí S, Del Barco S, Martin-Castillo B, Menendez JA.

Cell Cycle. 2010 Sep 15;9(18):3807-14. Epub 2010 Sep 25.

18.

The pathology of EMT in mouse mammary tumorigenesis.

Cardiff RD.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):225-33. doi: 10.1007/s10911-010-9184-y. Epub 2010 Jun 4. Review.

19.

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Joven J, Menendez JA.

Cell Cycle. 2010 Nov 15;9(22):4461-8. Epub 2010 Nov 15.

20.

Mammary stem cells and breast cancer--role of Notch signalling.

Farnie G, Clarke RB.

Stem Cell Rev. 2007 Jun;3(2):169-75. Review.

PMID:
17873349
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk